Manasanan Namhongsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manasanan Namhongsa has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Donraporn Daranarong
Multidisciplinary Research Institute, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Gareth Michael Ross
Department of Chemistry, Faculty of Science, Naresuan University, Phitsanulok 65000, Thailand
1 shared publication - Kittisak Yarungsee
Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Sukunya Ross
Naresuan University
1 shared publication - Tanyaluck Mekpothi
Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Winita Punyodom
Chiang Mai University
1 shared publication
Latest Publications
- Open Access
Ternary Blends of PLA with ATEC and TMC-200 as Medical-Grade Biodegradable Monofilaments for FDM 3D-Printing Applications
Poly(L-lactide) (PLA) is a promising biopolymer for biomedical applications due to its biodegradability and biocompatibility; however, its brittleness restricts its use in fused deposition modeling (FDM). To overcome this limitation, flexible PLA monofilaments with enhanced mechanical performance and printability were developed. In this study, PLA was melt-blended with acetyl triethyl citrate (ATEC, 1.0–5.0 wt%) as a plasticizer and zinc phenyl phosphonate (TMC-200, 0.3 wt%) as a nucleating agent. It was found that the PLA with 3.0 wt% ATEC (PLA/A) exhibited the greatest flexibility, while the addition of TMC-200 further improved tensile strength and ductility. Specifically, the ternary blend of PLA/TMC-200/ATEC (PLA/T/A) exhibited a synergistic effect, achieving superior mechanical properties (tensile strength: 35.0 MPa, elongation at break: 232.0%, compared to 12.1% for pure PLA) and raising the degree of crystallinity (Xc) from 4.7% to 45.0%. Monofilaments (1.70 ± 0.05 mm) fabricated from PLA/T/A exhibited smooth surfaces, balanced mechanical performance, and excellent cytocompatibility (over 99% cell viability in L929 fibroblasts). Moreover, FDM-printed specimens retained enhanced mechanical and thermal performance, demonstrating material stability after processing. Shelf-life testing further confirmed the structural integrity of PLA/T/A monofilament after 8 weeks at 50 °C. Overall, PLA/T/A provides an effective strategy for producing high-performance, medical-grade PLA monofilaments with improved toughness, printability, and biocompatibility, enabling their application in biomedical 3D printing.
Open AccessTernary Blends of PLA with ATEC and TMC-200 as Medical-Grade Biodegradable Monofilaments for FDM 3D-Printing Applications
Poly(L-lactide) (PLA) is a promising biopolymer for biomedical applications due to its biodegradability and biocompatibility; however, its brittleness restricts its use in fused deposition modeling (FDM). To overcome this limitation, flexible PLA monofilaments with enhanced mechanical performance and printability were developed. In this study, PLA was melt-blended with acetyl triethyl citrate (ATEC, 1.0–5.0 wt%) as a plasticizer and zinc phenyl phosphonate (TMC-200, 0.3 wt%) as a nucleating agent. It was found that the PLA with 3.0 wt% ATEC (PLA/A) exhibited the greatest flexibility, while the addition of TMC-200 further improved tensile strength and ductility. Specifically, the ternary blend of PLA/TMC-200/ATEC (PLA/T/A) exhibited a synergistic effect, achieving superior mechanical properties (tensile strength: 35.0 MPa, elongation at break: 232.0%, compared to 12.1% for pure PLA) and raising the degree of crystallinity (Xc) from 4.7% to 45.0%. Monofilaments (1.70 ± 0.05 mm) fabricated from PLA/T/A exhibited smooth surfaces, balanced mechanical performance, and excellent cytocompatibility (over 99% cell viability in L929 fibroblasts). Moreover, FDM-printed specimens retained enhanced mechanical and thermal performance, demonstrating material stability after processing. Shelf-life testing further confirmed the structural integrity of PLA/T/A monofilament after 8 weeks at 50 °C. Overall, PLA/T/A provides an effective strategy for producing high-performance, medical-grade PLA monofilaments with improved toughness, printability, and biocompatibility, enabling their application in biomedical 3D printing.